Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation
Squawk Pod29 Apr 2020

Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation

A new study from the NIAID revealed that at least 50% of Covid-19 patients treated with a 5-day dosage of Gilead’s Remdesivir reported improved symptoms and were discharged from the hospital within two weeks. Former FDA Commissioner Dr. Scott Gottlieb describes the treatment as “part of a better toolbox” for fighting the coronavirus, but “not a home run.” Plus, Mindy Grossman, CEO of WW International, (formerly known as Weight Watchers) discusses keeping her business and our bodies well during quarantine.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(1810)

Populært innen Business og økonomi

stopp-verden
e24-podden
rss-penger-polser-og-politikk
dine-penger-pengeradet
rss-borsmorgen-okonominyhetene
lydartikler-fra-aftenposten
rss-vass-knepp-show
finansredaksjonen
pengepodden-2
tid-er-penger-en-podcast-med-peter-warren
utbytte
stormkast-med-valebrokk-stordalen
livet-pa-veien-med-jan-erik-larssen
morgenkaffen-med-finansavisen
lederpodden
rss-markedspuls-2
okonomiamatorene
rss-sunn-okonomi
rss-investering-gjort-enkelt
rss-fri-kontantstrom